Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - levonorgestrel, quantity: 100 microgram; ethinylestradiol, quantity: 20 microgram - tablet, film coated - excipient ingredients: maize starch; gelatin; magnesium stearate; hypromellose; macrogol 4000; titanium dioxide; iron oxide red; lactose monohydrate - oral contraception

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - levonorgestrel, quantity: 100 microgram; ethinylestradiol, quantity: 20 microgram - tablet, film coated - excipient ingredients: gelatin; macrogol 4000; magnesium stearate; maize starch; lactose monohydrate; titanium dioxide; hypromellose - oral contraception

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - gestodene 60 µg (light yellow tablet); ethinylestradiol 15 µg (light yellow tablet); placebo (white tablet) - film-coated tablet - 60 µg - 15 µg - ethinylestradiol 15 µg; gestodene 60 µg; placebo - gestodene and ethinylestradiol

Ireland - English - HPRA (Health Products Regulatory Authority)

he clissmann - ethinylestradiol gestodene ethinylestradiol gestodene ethinylestradiol gestodene - tablets - 30/50 microgram

Namibia - English - Namibia Medicines Regulatory Council

pfizer laboratories (pty) ltd - gestodene, ethinylestradiol - tablets - each active tablet contains gestodene 0.006 mg, ethinylestradiol 0.015 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: povidone; magnesium stearate; lactose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - indicated for use as an oral contraceptive

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desogestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: povidone; titanium dioxide; magnesium stearate; maize starch; hypromellose; polysorbate 80; triacetin; indigo carmine aluminium lake; colloidal anhydrous silica; iron oxide yellow; lactose monohydrate - oral contraception

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - ethinylestradiol, quantity: 2.7 mg; etonogestrel, quantity: 11.7 mg - drug delivery system, vaginal - excipient ingredients: magnesium stearate; octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate; isododecane; ethylene/vinyl acetate copolymer; ethylene distearamide - nuvaring is for use for contraception.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 0.03 mg; levonorgestrel, quantity: 0.125 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; glycol montanate; sucrose; povidone; titanium dioxide; iron oxide yellow; calcium carbonate; glycerol; purified talc; macrogol 6000 - indicated for the prevention of pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 20 microgram; levonorgestrel, quantity: 100 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; macrogol 1500; magnesium stearate; microcrystalline cellulose; glycol montanate; polacrilin potassium; titanium dioxide; hypromellose; hyprolose; macrogol 400 - 1. the prevention of pregnancy. 2. the treatment of moderate acne vulgaris not controlled with topical preparations in post-menarchal, pre-menopausal women who accept contraception.